CoChat
Sign Up
Cited by 1,410

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells

Kim, Myung Soo, Haney, Matthew J., Zhao, Yuling, Mahajan, Vivek, Deygen, Irina, Klyachko, Natalia L., Inskoe, Eli, Piroyan, Aleksandr, Sokolsky, Marina, Okolie, Onyi, Hingtgen, Shawn D., Kabanov, Alexander V., Batrakova, Elena V.·2016·Nanomedicine: Nanotechnology, Biology and Medicine
DOI 10.1016/j.nano.2015.10.012PMC PMC4809755
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.nano.2015.10.012

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 41

  1. Gharpure, 2015, Nanotechnology: future of oncotherapy, Clin Cancer Res, 21, 3121, 10.1158/1078-0432.CCR-14-1189 · DOI
  2. Abu Lila, 2013, The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage, J Control Release, 172, 38, 10.1016/j.jconrel.2013.07.026 · DOI · Paper page
  3. Hayeshi, 2006, The potential inhibitory effect of antiparasitic drugs and natural products on P-glycoprotein mediated efflux, Eur J Pharm Sci, 29, 70, 10.1016/j.ejps.2006.05.009 · DOI
  4. Bauer, 2005, A phase I and pharmacologic study of idarubicin, cytarabine, etoposide, and the multidrug resistance protein (MDR1/Pgp) inhibitor PSC-833 in patients with refractory leukemia, Leuk Res, 29, 263, 10.1016/j.leukres.2004.07.002 · DOI
  5. Simpson, 2008, Proteomic profiling of exosomes: current perspectives, Proteomics, 8, 4083, 10.1002/pmic.200800109 · DOI
  6. Kalani, 2014, Exosomes: mediators of neurodegeneration, neuroprotection and therapeutics, Mol Neurobiol, 49, 590, 10.1007/s12035-013-8544-1 · DOI
  7. Dong, 2010, Nanomedicinal strategies to treat multidrug-resistant tumors: current progress, Nanomedicine (Lond), 5, 597, 10.2217/nnm.10.35 · DOI
  8. Yang, 2014, Nanomedicine to overcome cancer multidrug resistance, Curr Drug Metab, 15, 632, 10.2174/1389200215666140926154443 · DOI
  9. Koziara, 2006, In-vivo efficacy of novel paclitaxel nanoparticles in paclitaxel-resistant human colorectal tumors, J Control Release, 112, 312, 10.1016/j.jconrel.2006.03.001 · DOI
  10. Kalani, 2014, Curcumin-primed exosomes mitigate endothelial cell dysfunction during hyperhomocysteinemia, Life Sci, 107, 1, 10.1016/j.lfs.2014.04.018 · DOI
  11. Mathivanan, 2010, Exosomes: extracellular organelles important in intercellular communication, J Proteome, 73, 1907, 10.1016/j.jprot.2010.06.006 · DOI
  12. Alvarez-Erviti, 2011, Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes, Nat Biotechnol, 29, 341, 10.1038/nbt.1807 · DOI · Paper page
  13. Wahlgren, 2012, Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes, Nucleic Acids Res, 40, e130, 10.1093/nar/gks463 · DOI
  14. Shtam, 2013, Exosomes are natural carriers of exogenous siRNA to human cells in vitro, Cell Commun Signal, 11, 88, 10.1186/1478-811X-11-88 · DOI · Paper page
  15. Pan, 2012, Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi), Gut, 61, 1330, 10.1136/gutjnl-2011-300449 · DOI
  16. Chen, 2014, Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells, Hepatology, 59, 1118, 10.1002/hep.26768 · DOI
  17. Sun, 2010, A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes, Mol Ther, 18, 1606, 10.1038/mt.2010.105 · DOI
  18. Zhuang, 2011, Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain, Mol Ther, 19, 1769, 10.1038/mt.2011.164 · DOI · Paper page
  19. Tian, 2014, A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy, Biomaterials, 35, 2383, 10.1016/j.biomaterials.2013.11.083 · DOI
  20. Thery, 2009, Membrane vesicles as conveyors of immune responses, Nat Rev Immunol, 9, 581, 10.1038/nri2567 · DOI
  21. Pidaparti, 2012, Comparison of allergic reactions to pegasparaginase given intravenously versus intramuscularly, Pediatr Blood Cancer, 59, 436, 10.1002/pbc.23380 · DOI
  22. Batrakova, 2001, Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: selective energy depletion, Br J Cancer, 85, 1987, 10.1054/bjoc.2001.2165 · DOI
  23. Haney, 2015, Exosomes as drug delivery vehicles for Parkinson's disease therapy, J Control Release, 207, 18, 10.1016/j.jconrel.2015.03.033 · DOI · Paper page
  24. Laulagnier, 2005, Characterization of exosome subpopulations from RBL-2H3 cells using fluorescent lipids, Blood Cells Mol Dis, 35, 116, 10.1016/j.bcmd.2005.05.010 · DOI
  25. Boldytev, 2006, A synthesis and properties of new 4,4-difluoro-3a,4a-diaza-s-indacene (BODIPY)-labeled lipids, Bioorg Khim, 32, 87
  26. Batrakova, 2010, Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers, J Control Release, 143, 290, 10.1016/j.jconrel.2010.01.004 · DOI
  27. Batrakova, 2006, Alteration of genomic responses to doxorubicin and prevention of MDR in breast cancer cells by a polymer excipient: pluronic P85, Mol Pharm, 3, 113, 10.1021/mp050050g · DOI
  28. Ferrari, 1990, MTT colorimetric assay for testing macrophage cytotoxic activity in vitro, J Immunol Methods, 131, 165, 10.1016/0022-1759(90)90187-Z · DOI
  29. Sena-Esteves, 2004, Optimized large-scale production of high titer lentivirus vector pseudotypes, J Virol Methods, 122, 131, 10.1016/j.jviromet.2004.08.017 · DOI
  30. Brynskikh, 2010, Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson's disease, Nanomedicine (Lond), 5, 379, 10.2217/nnm.10.7 · DOI
  31. De Jong, 2008, Drug delivery and nanoparticles: applications and hazards, Int J Nanomedicine, 3, 133, 10.2147/IJN.S596 · DOI
  32. Batrakova, 1999, Fundamental relationships between the composition of pluronic block copolymers and their hypersensitization effect in MDR cancer cells, Pharm Res, 16, 1373, 10.1023/A:1018942823676 · DOI
  33. Batrakova, 2003, Optimal structure requirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells, J Pharmacol Exp Ther, 304, 845, 10.1124/jpet.102.043307 · DOI
  34. Batrakova, 2003, Sensitization of cells overexpressing multidrug-resistant proteins by pluronic P85, Pharm Res, 20, 1581, 10.1023/A:1026179132599 · DOI
  35. Kalra, 2013, Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma, Proteomics, 13, 3354, 10.1002/pmic.201300282 · DOI
  36. Mulcahy, 2014, Routes and mechanisms of extracellular vesicle uptake, J Extracell Vesicles, 3, 10.3402/jev.v3.24641 · DOI · Paper page
  37. Safaei, 2005, Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells, Mol Cancer Ther, 4, 1595, 10.1158/1535-7163.MCT-05-0102 · DOI
  38. Yamagishi, 2013, P-glycoprotein mediates drug resistance via a novel mechanism involving lysosomal sequestration, J Biol Chem, 288, 31761, 10.1074/jbc.M113.514091 · DOI
  39. Pascucci, 2014, Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery, J Control Release, 192, 262, 10.1016/j.jconrel.2014.07.042 · DOI · Paper page
  40. Finn, 2012, Immuno-oncology: understanding the function and dysfunction of the immune system in cancer, Ann Oncol, 23, viii6, 10.1093/annonc/mds256 · DOI
  41. Parolini, 2009, Microenvironmental pH is a key factor for exosome traffic in tumor cells, J Biol Chem, 284, 34211, 10.1074/jbc.M109.041152 · DOI

Cited by

Sorted by citations

Metadata

Authors
Kim, M. S., Haney, M. J., Zhao, Y., Mahajan, V., Deygen, I., Klyachko, N. L., Inskoe, E., Piroyan, A., Sokolsky, M., Okolie, O., Hingtgen, S. D., Kabanov, A. V., & Batrakova, E. V.
Venue
Nanomedicine: Nanotechnology, Biology and Medicine
Publisher
Elsevier BV
Published
2016-04
Volume
12
Issue
3
Pages
655-664
ISSN
1549-9634
DOI
10.1016/j.nano.2015.10.012
PMC
PMC4809755
Cited by
1,410
References
6
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review